NCT06625645

Brief Summary

Comparing between different intracanal medications with different combination forms of Modified Triple Antibiotic Paste, Calcium Hydroxide and Chlorehexidine, regarding antimicrobial efficacy through bacterial reduction count of enterococcus Faecalis and regarding clinical and radiographic success in non vital primary teeth necessitating pulpectomy with follow up time 1 year.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 3, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

October 17, 2024

Status Verified

October 1, 2024

Enrollment Period

4 months

First QC Date

September 28, 2024

Last Update Submit

October 16, 2024

Conditions

Keywords

Necrotic Primary TeethApical PeriodontitisNon Vital primary teethperiapical pathosis of primary teethintracanal medicationtriple antibiotic pasteenterococcus faecalisMicrobiologybacterial reduction

Outcome Measures

Primary Outcomes (1)

  • Enterococcus faecalis bacterial reduction

    Samples from canal using paper point size 20 with pumping action from the widest canal three times one after the access and gaining patency, second one after chemomechanical preparation and the third one after 7 days from intracanal medication insertion in the canal, then the samples will be placed in sterile vials with thioglycolate (transport medium). The vials will be sealed tightly to avoid contamination and labeled. The labeled vials will be kept in a freezer and will be sent to the laboratory within 1 hour of collection, and samples will be assessed for total E. faecalis count.

    3 times, one after the access and gaining patency, second one after chemomechanical preparation and the third one after 7 days from intracanal medication insertion in the canal

Secondary Outcomes (1)

  • Clinical success

    3,6 and 12 months

Other Outcomes (1)

  • Radiographic success

    6 and 12 months

Study Arms (2)

Calcium Hydroxide mixed with saline as control intracanal medication

ACTIVE COMPARATOR

using calcium hydroxide with saline as control intracanal medication for necrotic primary molars

Combination Product: calcium hydroxide mixed with saline as intracanal medication

different types and combinations of intracanal medications for necrotic primary molars

EXPERIMENTAL
Combination Product: Modified triple antibiotic paste (TAP) mixed with chlorehexidineCombination Product: Modified Triple Antibiotic Paste mixed with salineCombination Product: Calcium Hydroxide mixed with chlorohexidine Intracanal medication

Interventions

M-TAP with CHX 2%

different types and combinations of intracanal medications for necrotic primary molars

M-TAP mixed with saline

different types and combinations of intracanal medications for necrotic primary molars

calcium hydroxide powder mixed with CHX 2% solution as intracanal medication

different types and combinations of intracanal medications for necrotic primary molars

calcium hydroxide mixed with saline as intracanal medication for necrotic primary molars

Calcium Hydroxide mixed with saline as control intracanal medication

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Primary molars necessitating pulpectomy diagnosed with deep dental caries with pulp necrosis, apical periodontitis and periapical pathosis or both.
  • Non-Vital pulps.
  • Negative response to hot or cold pulp tester (ethyl chloride spray ).
  • Decayed tooth with spontaneous unprovoked long dull aching pain showing signs of necrosis of the pulp

You may not qualify if:

  • Medically compromised and uncooperative children
  • Tooth indicated for extraction
  • Mobile teeth (Miller's Grade 2 or more)
  • teeth with more than two-thirds of root resorption
  • previous endodontic treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Periapical Periodontitis

Interventions

Sodium Chloride

Condition Hierarchy (Ancestors)

Periapical DiseasesJaw DiseasesStomatognathic DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Central Study Contacts

Mahy kamar Mahy A.Raouf Kamar, Assistant Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

September 28, 2024

First Posted

October 3, 2024

Study Start

January 1, 2025

Primary Completion

May 1, 2025

Study Completion

January 1, 2026

Last Updated

October 17, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share